期刊文献+

坦索罗辛联合索利那新治疗经尿道前列腺电切术后不稳定膀胱的效果观察 被引量:1

Effect of tansoloxin combined with sorina on unstable bladder after TURP was observed
下载PDF
导出
摘要 目的:观察用坦索罗辛联合索利那新治疗经尿道前列腺电切术(TURP)后不稳定膀胱的效果。方法:选取2015年1月至2017年1月期间在南充市东方医院进行TURP后发生不稳定膀胱的81例前列腺增生(BPH)患者作为研究对象。根据治疗方法的不同将其分为对照组(39例)和研究组(42例)。为对照组患者单用索利那新进行治疗,为研究组患者联用索利那新和坦索罗辛进行治疗。然后对比两组患者治疗的效果、留置导尿管的时间、膀胱痉挛症状消失的时间、发生膀胱痉挛的频率、VAS评分、IPSS评分和QOL评分。结果:研究组患者治疗的有效率高于对照组患者,P<0.05。治疗后,研究组患者留置导尿管的时间、膀胱痉挛症状消失的时间均短于对照组患者,其发生膀胱痉挛的频率、VAS评分、IPSS评分、QOL评分均低于对照组患者,P<0.05。结论:用坦索罗辛联合索利那新治疗TURP后不稳定膀胱的效果良好。 objective: to observe the effect of tansoloxin combined with sorina on unstable bladder after transurethral prostatectomy(TURP). Methods: 81 patients with prostate hyperplasia(BPH) who developed unstable bladder after TURP at dongfang hospital of nanchong city from January 2015 to January 2017 were selected as the study subjects. It was divided into a control group(39 cases) and a research group(42 cases) according to the different treatment methods. Patients in the control group were treated with sorethoxin alone and patients in the study group were treated with sorethoxin and tamsolosin in combination. The effects of treatment, time of indwelling urethral catheter, time of disappearance of bladder spasm, frequency of bladder spasm, VAS score, IPSS score and QOL score were compared between the two groups. Results: the effective rate of the study group was higher than that of the control group, P 〈 0.05. After treatment, the team time period of detaining urethral catheter, bladder spasm in patients with symptoms disappear time is shorter than the control group, the frequency of the occurrence of bladder spasm, VAS score, IPSS score, QOL scores are lower than the control group patients, P 〈 0.05). Conclusion: tansoloxin combined with solina is effective in the treatment of unstable bladder after TURP.
作者 雍竞 Yong Jing(Department of urology, dongfang hospital, nanchong city, sichuan 63700)
出处 《当代医药论丛》 2018年第8期110-111,共2页
关键词 不稳定膀胱 坦索罗辛 索利那新 经尿道前列腺电切术 unstable bladder Tamsolosin Solina new TURP
  • 相关文献

参考文献6

二级参考文献49

  • 1童滨,陈哲,陈飘.三联用药治疗前列腺摘除术后不稳定膀胱[J].现代泌尿外科杂志,2004,9(4):225-225. 被引量:3
  • 2唐来坤,潘良,郦俊生,田峰,杨银才,李立,沙键,程捷,赵弈文,方超.良性前列腺增生向膀胱内突入部分所成夹角评价膀胱出口梗阻程度的意义[J].中华泌尿外科杂志,2007,28(6):411-413. 被引量:12
  • 3王玉忠.非那雄胺、盐酸特拉唑嗪联合应用治疗老年性前列腺增生30例[J].局解手术学杂志,2007,16(3):192-192. 被引量:3
  • 4Dmochowski RR, Staskin D. Overactive bladder in men: special considerations for evaluation and management. Urology, 2002, 60 (5 Suppl 1) : 56-62.
  • 5Lee KS, Choo MS, Kim DY, et al. Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastroin- testinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study. J Urol,2005, 174(4) :1334-1338.
  • 6Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolterodine and tam- sulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled triM. JAMA, 2006, 296(19) : 2319-2328.
  • 7Ohtake A, Saitoh C, Yuyama H, et al. Pharmacological character- ization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Biol Pharm Bull, 2007, 30(1) : 54-58.
  • 8Canby-Hagino ED,Brand TC,Hernandez J,et al. Chemoprevention ofprostate cancer with finasteride [ J ]. Expert Opin Pharmacother,2006,7:899-905.
  • 9Pareek G,Shevchukm M, Armenakasna A,et al. The effect of finas-teride on the expression of vascular endothelial growth factor and mi-crovessel density : a possible mechanism for decreased prostaticbleeding in treated patients[ J]. J Urol,2003 ,169( 1) :20-23.
  • 10Trachtenberg J. Treatment of lower urinary tract symptoms suggestiveof benign prostatic hyperplasia in relation to the patient ’s rist profilefor progression[ J]. J BJU Int,2005 ,95 ( Suppl 4) :6-11.

共引文献62

同被引文献15

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部